Accuray Incorporated ( ARAY ) Q1 2026 Earnings Call November 5, 2025 4:30 PM EST Company Participants Stephen Monroe Stephen LaNeve - President, CEO & Director Ali Pervaiz - Senior VP & CFO Conference Call Participants Marie Thibault - BTIG, LLC, Research Division Presentation Operator Good day, and welcome to the Accuray First Quarter Fiscal 2026 Financial Results Conference Call. [Operator Instructions].
Accuray Incorporated (NASDAQ:ARAY ) Shareholder/Analyst Call September 29, 2025 4:30 PM EDT Company Participants Suzanne Winter - President, CEO & Director Mu Lee - Senior Vice President of Research & Product Development Seth Blacksburg - Senior VP & Chief Medical Officer Conference Call Participants Shalom Kalnicki Jonathan Haas Giuseppe Sasso John Kresl Presentation Suzanne Winter President, CEO & Director Good afternoon, everyone, and welcome to Accuray's Analyst briefing. We're coming to you from the ASTRO conference in San Francisco for 2025.
ARAY stock down after Q4 earnings miss estimates, with product sales hit by tariffs and regional demand softness.
Accuray Incorporated (NASDAQ:ARAY ) Q4 2025 Earnings Conference Call August 13, 2025 4:30 PM ET Company Participants Ali Pervaiz - Senior VP & CFO Suzanne Winter - President, CEO & Director Conference Call Participants Jason Hart Wittes - ROTH Capital Partners, LLC, Research Division Marie Yoko Thibault - BTIG, LLC, Research Division Operator Welcome to the Accuray Fourth Quarter Fiscal 2025 Financial Results Conference Call. [Operator Instructions] Please note, this event is being recorded.
Accuray (ARAY) reported break-even quarterly earnings per share versus the Zacks Consensus Estimate of $0.03. This compares to earnings of $0.03 per share a year ago.
ARAY rides strong global demand and CyberKnife momentum, but order declines and backlog pressure temper the outlook.
ARAY continues to witness strength in its flagship, CyberKnife system, along with robust global performance.
Accuray (ARAY) reported earnings 30 days ago. What's next for the stock?
ARAY continues to witness strength in its flagship, CyberKnife system, along with robust global performance.
Accuray has consistently struggled with execution, and now tariffs threaten to significantly impact the company's business in China - it's most promising growth driver. Recent Q3 results showed revenue growth but were overshadowed by weaker guidance and declining orders, particularly impacted by U.S.-China tariffs. The competition in China is intensifying, with local and global players ramping up efforts, challenging Accuray's ability to capitalize on a large market opportunity.
Accuray reports solid fiscal third-quarter results, witnessing growth in Product & Services revenues and reduced operating expenses.
Accuray Incorporated (NASDAQ:ARAY ) Q3 2025 Earnings Call April 30, 2025 4:30 PM ET Company Participants Jesse Chew - Chief Legal Officer Suzanne Winter - President and Chief Executive Officer Ali Pervaiz - Chief Financial Officer Conference Call Participants Brooks O'Neil - Lake Street Capital Markets Marie Thibault - BTIG Jason Wittes - ROTH Capital Operator Good day and welcome to the Accuray Third Quarter Fiscal 2025 Financial Results Conference Call. [Operator Instructions] Please note this event is being recorded.